Torsades de pointes complicating treatment with terodiline.
作者信息
McLeod A A, Thorogood S, Barnett S
出版信息
BMJ. 1991 Jun 15;302(6790):1469. doi: 10.1136/bmj.302.6790.1469-c.
Abstract
摘要
相似文献
1
Torsades de pointes complicating treatment with terodiline.特罗地林治疗引发尖端扭转型室性心动过速
BMJ. 1991 Jun 15;302(6790):1469. doi: 10.1136/bmj.302.6790.1469-c.
2
Torsades de pointes complicating treatment with terfenadine.特非那定治疗引发的尖端扭转型室性心动过速。
BMJ. 1991 Jun 15;302(6790):1469. doi: 10.1136/bmj.302.6790.1469-b.
3
Torsades de pointes complicating treatment with terfenadine.特非那定治疗引发的尖端扭转型室性心动过速。
BMJ. 1991 Jul 6;303(6793):58. doi: 10.1136/bmj.303.6793.58-c.
4
Torsades de pointes occurring in association with terfenadine use.与使用特非那定相关的尖端扭转型室性心动过速。
JAMA. 1990 Dec 5;264(21):2788-90.
5
Torsades de pointes from terfenadine and sotalol given in combination.特非那定与索他洛尔联合使用导致尖端扭转型室性心动过速。
Pacing Clin Electrophysiol. 1996 Oct;19(10):1519-21. doi: 10.1111/j.1540-8159.1996.tb03169.x.
6
Terfenadine should be withdrawn from clinical use.特非那定应停止临床使用。
J Assoc Physicians India. 1999 Sep;47(9):943.
7
Torsades de pointes with terfenadine ingestion.服用特非那定后发生尖端扭转型室速。
Am J Emerg Med. 1997 Sep;15(5):542-3. doi: 10.1016/s0735-6757(97)90206-0.
8
Cardiovascular toxicity of antihistamines.抗组胺药的心血管毒性。
Otolaryngol Head Neck Surg. 1994 Sep;111(3 Pt 2):348-54. doi: 10.1177/01945998941113p203.
9
Non-sedating antihistamines and cardiac arrhythmia.非镇静性抗组胺药与心律失常
Lancet. 1997 Oct 18;350(9085):1115-6. doi: 10.1016/S0140-6736(05)63783-X.
10
Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.房室传导阻滞引起的长期心动过缓可使犬心脏发生重塑，以检测组胺H1阻滞剂特非那定诱导的尖端扭转型室性心律失常。
Br J Pharmacol. 2006 Mar;147(6):634-41. doi: 10.1038/sj.bjp.0706493.
引用本文的文献
1
Torsade de pointes associated with the combination of solifenacin and clenbuterol for urinary incontinence.与索利那新和克仑特罗联合使用治疗尿失禁相关的尖端扭转型室性心动过速。
J Cardiol Cases. 2013 Dec 12;9(3):91-93. doi: 10.1016/j.jccase.2013.10.009. eCollection 2014 Mar.
2
Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.发表药品不良反应病例报告的重要性：促进公众健康并推动药理学与治疗学发展
Drug Saf Case Rep. 2017 Sep 20;4(1):11. doi: 10.1007/s40800-017-0053-0.
3
Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.老年患者药物性尖端扭转型室速中QT间期延长剂的鲁莽使用。
Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.
4
QT prolongation and torsade de pointes associated with solifenacin in an 81-year-old woman.一名81岁女性使用索利那新后出现QT间期延长及尖端扭转型室性心动过速
Br J Clin Pharmacol. 2008 Dec;66(6):896-7. doi: 10.1111/j.1365-2125.2008.03298.x.
5
Electrophysiological profile of propiverine--relationship to cardiac risk.丙哌维林的电生理特征——与心脏风险的关系
Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):431-40. doi: 10.1007/s00210-007-0231-1. Epub 2007 Dec 19.
6
The Q-T interval and antimuscarinic drugs.Q-T间期与抗胆碱能药物。
Curr Urol Rep. 2005 Nov;6(6):405-9. doi: 10.1007/s11934-005-0033-2.
7
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.药物诱导的尖端扭转型室性心动过速的药物遗传学方面：改善临床药物开发和处方的潜在工具。
Drug Saf. 2004;27(3):145-72. doi: 10.2165/00002018-200427030-00001.
8
Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.尿失禁药物S-奥昔布宁和特罗地林对心脏钾离子电流及动作电位影响的差异
Br J Pharmacol. 2000 Sep;131(2):245-54. doi: 10.1038/sj.bjp.0703595.
9
Block and modified gating of cardiac calcium channel currents by terodiline.特罗地林对心脏钙通道电流的阻断及改良门控作用
Br J Pharmacol. 1999 Aug;127(8):1837-45. doi: 10.1038/sj.bjp.0702713.
10
Concentration dependent cardiotoxicity of terodiline in patients treated for urinary incontinence.替地定在治疗尿失禁患者中浓度依赖性的心脏毒性。
Br Heart J. 1995 Jul;74(1):53-6. doi: 10.1136/hrt.74.1.53.
本文引用的文献
1
Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.特罗地林。其药理特性及治疗尿失禁的应用综述。
Drugs. 1990 Nov;40(5):748-61. doi: 10.2165/00003495-199040050-00008.
2
Ventricular arrhythmias caused by prenylamine.普尼拉明引起的室性心律失常。
Br Med J. 1977 Sep 3;2(6087):608-9. doi: 10.1136/bmj.2.6087.608.
Zotero 插件